According to the study conducted by Wolters Kluwer Health, in patients undergoing reconstructive surgery of the face, treatment with botulinum toxin A (BTX-A, or Botox) can improve the final appearance of surgical scars.In each patient, half of the facial scar was randomly assigned to treatment with BTX-A or inactive saline (placebo) solution, injected immediately at the end of surgery.The study included 16 patients undergoing facial plastic and reconstructive surgery at the authors department over a four-month period. The scars averaged 6.Six months later, independent plastic surgeons made measurements and rated the appearance of both sides of the scar.The Botox-treated sides were also lower and narrower than then comparison sides. They proposed further studies comparing the effects of BTX-A on surgical scars with different injection techniques and in different locations on the face.”This study demonstrates that early post-surgical botulinum toxin injections can produce better, narrower, and flatter facial surgical scars,” according to the study by XiaoXi Lin and colleagues. Lin and coauthors speculated.Washington: Botox improves appearance of facial scars in reconstructive surgery, a new study Reflex Electroform Mold Insert Manufacturers has reported.Injection of BTX-A – best known by the brand name Botox – is widely used for the treatment of facial lines and wrinkles.
The study is published in the Plastic and Reconstructive Surgery. The results added to the growing list of clinical applications for BTX-A – beyond its cosmetic use in treating facial lines and wrinkles. Most were undergoing surgery for some type of disfiguring facial birthmarks, such as a melanocytic nevus or port wine stain. The patients averaged 12 years of age. “This relief of tension may help prevent facial scar widening, hypertrophy, and hyperpigmentation”..In recent years, BTX-A has also been effectively used to treat a wide range of non-cosmetic problems as well. By several measures, the final appearance of the scar was significantly better on the half treated with BTX-A.They cited previous studies suggesting that BTX-A might also inhibit certain cells (fibroblasts) and mediators involved in scar.97 on the placebo-treated half.How does BTX-A affect the process of scar formation? “Temporary muscular paralysis induced by BTX-A could decrease movement and stress around a healing wound,” Dr.74 centimeters in length, with a range of three to 16 centimeters (about one to six inches).The authors noted some important limitations of their preliminary study, particularly the small number of patients included.On a 0- to 10-point scale (with 0 being worst and 10 being best), the surgeons ratings for overall scar appearance averaged 5.76 on the half treated with BTX-A versus 4. Other scar characteristics (color, pliability, and vascularity) were not significantly different.The study included follow-up data in 14 patients. It is the most common cosmetic procedure in the United States, with about 7 million BTX-A injection procedures performed in 2016, according to ASPS statistics
injection